Metoprolol 5 mg IV Administration Protocol
Administer metoprolol 5 mg as an intravenous bolus over approximately 2 minutes, repeated every 5 minutes for up to 3 doses (total 15 mg maximum) if tolerated, with continuous monitoring of blood pressure, heart rate, and ECG during administration 1, 2.
Route and Infusion Rate
- Route: Intravenous bolus injection
- Dose: 5 mg per bolus
- Rate: Administer over approximately 2 minutes 2
- Frequency: May repeat every 5 minutes as tolerated 1
- Maximum: Up to 3 doses (15 mg total) 1, 2
Clinical Context and Indications
The 5 mg IV dose is specifically indicated for:
- Acute myocardial infarction (early treatment phase) 1, 2
- Refractory hypertension in STEMI patients 1
- Ongoing ischemia without contraindications 1
Absolute Contraindications - DO NOT GIVE IF:
- Signs of heart failure (rales, S3 gallop, jugular venous distension)
- Low output state (cool extremities, altered mental status, oliguria)
- Increased risk for cardiogenic shock, particularly:
- Age >70 years
- Systolic BP <120 mm Hg
- Heart rate >110 bpm or <60 bpm
- Prolonged time since symptom onset 1
- High-grade AV block: PR interval >0.24 seconds, second- or third-degree heart block 1
- Active asthma or reactive airways disease 1
- Systolic BP <90 mm Hg or >30 mm Hg below baseline 1
Required Monitoring
Must be administered in an intensive monitoring setting 2:
- Continuous ECG monitoring
- Blood pressure measurement before each dose
- Heart rate assessment before each dose
- Clinical assessment for signs of heart failure or cardiogenic shock
Titrate to heart rate and blood pressure response - hold subsequent doses if:
- Systolic BP drops below 90 mm Hg
- Heart rate falls below 50-60 bpm
- Development of AV block
- Signs of heart failure emerge
Transition to Oral Therapy
If patient tolerates full IV dose (15 mg total):
- Start metoprolol tartrate 50 mg orally every 6 hours
- Begin 15 minutes after the last IV dose
- Continue for 48 hours
- Then transition to 100 mg twice daily for maintenance 1, 2
If patient shows intolerance to full IV dose:
- Start 25-50 mg orally every 6 hours (depending on degree of intolerance)
- Begin 15 minutes after last IV dose or when clinically stable 2
Critical Pitfalls to Avoid
The COMMIT/CCS-2 trial demonstrated that early IV metoprolol followed by high-dose oral therapy showed increased cardiogenic shock rates, especially on days 0 and 1, particularly in elderly patients and those with hemodynamic compromise 1. This underscores the importance of strict adherence to contraindication screening.
Do not administer to patients with multiple risk factors for cardiogenic shock - the greater the number of risk factors present (age >70, SBP <120, HR >110 or <60, delayed presentation), the higher the risk 1.
Special Populations
- Elderly (>65 years): Use cautiously; higher risk of cardiogenic shock and adverse effects 1, 2
- Hepatic impairment: Blood levels increase substantially; if IV metoprolol is necessary, use with extreme caution and consider lower doses 2
- Renal impairment: No dose adjustment required 2
Storage and Preparation
- Store at 20-25°C (68-77°F)
- Protect from light; retain in carton until use
- Do not freeze
- Inspect visually for particulate matter before administration 2